Next 10 |
home / stock / bayzf / bayzf news
2024-07-25 22:03:11 ET More on Bayer Bayer: Small Signs Of Improvement Are Not Enough Bayer Q1 2024 Earnings Call Transcript Bayer Q1 2024 Earnings Call Presentation Read the full article on Seeking Alpha For further details see: Bayer's Monsanto ...
2024-07-24 08:10:00 ET Summary Investment activity remained high in June, focusing on BDCs aiming to increase dividend income by at least $100 each month. Adjusted dividend income in June is up 27% Y/Y and 5% vs the previous quarter. Main portfolio picks included Ares Capital,...
2024-07-17 14:56:50 ET More on Bayer Bayer: Small Signs Of Improvement Are Not Enough Bayer AG (BAYZF) Q1 2024 Earnings Call Transcript Bayer Aktiengesellschaft 2024 Q1 - Results - Earnings Call Presentation Bayer's $2.25B Roundup verdict cut to $400M by Penn...
2024-07-17 13:00:00 ET Summary ORIC Pharmaceuticals, Inc. expects updated results from the phase 1b study, using ORIC-114 for the treatment of patients with mutated NSCLC, in the 1st half of 2025. The global non-small cell lung cancer market size is projected to reach $36.9 billio...
2024-07-17 07:16:11 ET More on Johnson & Johnson Johnson & Johnson Q2 Earnings Preview: Scrutinizing Its Earnings Quality Johnson & Johnson: Remaining A Buy Despite Remaining Risks Johnson & Johnson: A Lot Of Moving Parts, But Perhaps Finally Lurching...
2024-06-19 08:10:00 ET Summary Investment activity remained high in April, focusing on BDCs aiming to increase dividend income by at least $100 each month. Main portfolio picks included Ares Capital, Hercules Capital, Goldman Sachs BDC, and MidCap Financial Investment Corporation....
2024-06-14 12:58:31 ET More on Ocular Therapeutix Ocular Therapeutix: Betting On Axpaxli For A Major Market Breakthrough Ocular Therapeutix: Unveiling Pipeline Progress (AXPAXLI, PAXTRAVA) And Q1 Results Ocular Therapeutix's Impressive Surge: A Strategic Insight ...
2024-06-08 10:19:36 ET More on AstraZeneca, Bristol-Myers, etc. Merck & Co., Inc. (MRK) Investor Event at ASCO 2024 (Transcript) Bristol-Myers: Why I Am Buying More Of This Falling Knife, Yielding 5.84% Bristol-Myers Squibb: Looking Beyond The One-Time Quarterly ...
2024-06-04 19:19:54 ET More on Bayer Bayer: Small Signs Of Improvement Are Not Enough Bayer Q1 2024 Earnings Call Transcript Bayer Q1 2024 Results - Earnings Call Presentation Read the full article on Seeking Alpha For further details see: Bayer's...
2024-06-04 10:26:59 ET More on Bristol-Myers Squibb Company Bristol-Myers: Why I Am Buying More Of This Falling Knife, Yielding 5.84% Bristol-Myers Squibb: Looking Beyond The One-Time Quarterly Loss Bristol Myers Squibb: 5.5% Yielder Has Been Crushed In What Could Be...
News, Short Squeeze, Breakout and More Instantly...
Bayer AG Registered Shares Company Name:
BAYZF Stock Symbol:
OTCMKTS Market:
NORTHAMPTON, MA / ACCESSWIRE / August 29, 2023 / Bayer - As climate change quickens, societal expectations increase and the threat of resistance grows, new crop protection solutions are imperative. Advances in the life sciences and data-driven technologies hold the key to expanding our pipeline ...
Monsanto Must Face Georgia State Jurors in Lawsuit Over Cancer-Causing Roundup Herbicide PR Newswire 11th Circuit opinion finds chemical giant subject to state's warning label laws Nachawati Law Group trial lawyers gearing up for next Roundup cancer trial in Au...
Bayer Runs Out of Appeals at US Supreme Court as Thousands of Cancer Lawsuits Await over Roundup Herbicide PR Newswire Fears Nachawati trial lawyers gearing up for next Roundup cancer trial in August WASHINGTON , June 22, 2022 /PRNewswire/ -- Baye...